Defining the plasma metabolomic and lipidomic signature in SARS-CoV-2 infection PLOS Pathogens journals.plos.org/plospathogens/…

One dose of BNT162b2 mRNA vaccine in ex COVID-19 subjects is enough! Our preprint is online! medrxiv.org/content/10.110…

Houston, we have a problem with the graphical abstract! One more reason to read the full paper 🙃. One dose Pfizer/Biontech vaccine is enough in recovered COVID-19 subjects...

Now online, our study on immunological memory to SARS-CoV-2 in a cohort of Serie A football players! onlinelibrary.wiley.com/doi/full/10.10…

Just Published: Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine: buff.ly/3bLMBHz #Commentary #Covid_19

First dose of mRNA vaccine in people recovered from #COVID_19: buff.ly/3xHcYb5, buff.ly/35EqE9U In this issue of the JCI two studies explored antibody responses in individuals with previous exposure to SARS-CoV-2. Humanitas Milano Università di Firenze

Now online our review on the role of ILC2 in host protection and asthma pathogenesis sciencedirect.com/science/articl…

Is one vaccine dose enough if you’ve had COVID? What the science says nature.com/articles/d4158…

📣📣📣 Welcome letter from the new SIICA president Marco Cassatella. Stay tuned for the upcoming initiatives 🔬 BTW buckle up for the next #SIICA national #conference in #Naples 22-25 May 2022

Our latest finding: JAK-inhibitor ruxolitinib impairs Spike-specific antibody production following administration of the first dose of COVID-19 mRNA vaccine. onlinelibrary.wiley.com/doi/abs/10.100…

Just published, our article reviewing the main features of dysregulated immune response in COVID-19. #SeminarsInImmunology doi.org/10.1016/j.smim…

Now online, our case report describing long-lasting, uncomplicated SARS-CoV-2 infection in an AIDS patient with severe CD4 deficiency. European Journal of Immunology onlinelibrary.wiley.com/doi/abs/10.100…

We are pleased to announce that the XIII National #Congress #SIICA from 23 to 26 May 2022 at the Unina Federico II Abstract submission deadline 12 Jan 2022: siica2022.it/abstracts/ STAY TUNED! Visit the congress website SIICA2022.IT

Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies medrxiv.org/cgi/content/sh… #medRxiv

Don’t forget to submit your abstract for the XIII National #SIICA #Congress May 23-26 2022 in the beautiful Naples, as shown in this clip from #StanotteaNapoli by Alberto Angela Rai Deadline Jan 26th! #Immunology #science #conference fb.watch/avJOYLzXd3/

Our article showing conserved CD4 T cell response against #SARS_CoV_2 variants of concern (including Omicron) has been accepted for publication in Frontiers - Immunology. Good news for #COVID19 recovered and vaccinated individuals. Full article available soon. frontiersin.org/articles/10.33…

We are thrilled to announce the four Keynote Speakers of the XIII National #SIICA #Congress May 23-26 2022 in #Naples Maria Grazia #Roncarolo Giorgio #Trinchieri Luigi NALDINI and Ivan Zanoni Stanford University Ospedale San Raffaele National Cancer Institute Boston Children's #immunology #conference #science

Our paper on immunological memory following #SARSCoV2 infection or (/and) vaccination is finally out in Journal of Clinical Investigation. Antibodies decline, #memory B and CD4+ T cells persist. A booster dose is more effective in those without prior infection. jci.org/articles/view/…

Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization medrxiv.org/cgi/content/sh… #medRxiv

Alarming inflammation: the TGFβ1–Nrp1 pathway upregulates the IL-33 axis in lung ILC2s. Lorenzo Salvati, Alessio Mazzoni Read👉 doi.org/10.1111/all.15… See more papers published in #Allergy 👉journalallergy.com Alessio Mazzoni #Allergy_journal